The state of Mississippi currently has 2 active clinical trials seeking participants for Primary Biliary Cholangitis research studies. These trials are conducted in various cities, including Jackson, Tupelo, Hattiesburg and Flowood.
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis
Recruiting
The purpose of this clinical research study is to learn more about the use of the study medicine, volixibat, for the treatment of pruritus (itching) associated with Primary Biliary Cholangitis (PBC), and to assess the possible impact on the disease progression of PBC.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
02/03/2025
Locations: Jackson Liver and GI Specialists, Jackson, Mississippi
Conditions: Primary Biliary Cholangitis, PBC
An Open-Label Study Following Oral Dosing of Seladelpar to Subjects With Primary Biliary Cholangitis (PBC) and Hepatic Impairment (HI)
Recruiting
The Effect of Hepatic Impairment on The Pharmacokinetics of Seladelpar: An Open-Label Study Following Oral Dosing of Seladelpar to Subjects with Primary Biliary Cholangitis (PBC) and Hepatic Impairment (HI)
Gender:
ALL
Ages:
Between 18 years and 80 years
Trial Updated:
11/11/2024
Locations: Southern Therapy and Advanced Research LLC, Jackson, Mississippi
Conditions: Primary Biliary Cholangitis, Compensated Cirrhosis, Hepatic Impairment